LPL Financial’s Biogen BIIB Stock Holding History

LPL Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,000	Closed	-$388K	–	5297
2024 Q3	$388K	Hold	2,000	–	–	﹤0.01%	4224
2024 Q2	$464K	Buy	+2,000	New	+$435K	﹤0.01%	3937

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial's BIIB Position: Q2 2026 in Review

LPL Financial increased its Biogen (BIIB) stake by 17% in Q2 2026, buying an estimated $2.63M and bringing the position to 95,466 shares worth $20.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

LPL Financial first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

LPL Financial held 95,466 shares of Biogen worth $20.6M as of Q2 2026.
LPL Financial bought 13,746 Biogen shares in Q2 2026, an estimated $2.63M.
Biogen made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #1548 holding.
LPL Financial first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.